CINECA IRIS Institutional Research Information System

FALLAHI, POUPAK
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.400
AS - Asia 10.663
EU - Europa 8.267
SA - Sud America 2.002
AF - Africa 367
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 45.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.798
SG - Singapore 3.250
IT - Italia 3.249
CN - Cina 2.861
HK - Hong Kong 1.905
BR - Brasile 1.676
SE - Svezia 1.200
VN - Vietnam 1.079
BG - Bulgaria 710
DE - Germania 619
FI - Finlandia 528
CA - Canada 441
FR - Francia 428
RU - Federazione Russa 409
GB - Regno Unito 390
TR - Turchia 387
IN - India 231
UA - Ucraina 184
JP - Giappone 138
IQ - Iraq 125
AR - Argentina 115
BD - Bangladesh 112
NL - Olanda 110
KR - Corea 106
CI - Costa d'Avorio 84
MX - Messico 77
PL - Polonia 65
ID - Indonesia 61
ZA - Sudafrica 61
CH - Svizzera 60
ES - Italia 59
AT - Austria 55
PK - Pakistan 52
EC - Ecuador 47
SA - Arabia Saudita 47
CO - Colombia 41
MA - Marocco 41
SN - Senegal 41
BE - Belgio 38
UZ - Uzbekistan 37
VE - Venezuela 37
NG - Nigeria 32
PH - Filippine 31
PY - Paraguay 29
IE - Irlanda 25
KE - Kenya 24
CZ - Repubblica Ceca 22
MY - Malesia 22
JO - Giordania 21
TN - Tunisia 21
AE - Emirati Arabi Uniti 20
AU - Australia 20
NP - Nepal 20
UY - Uruguay 19
LT - Lituania 18
TH - Thailandia 17
EG - Egitto 16
IR - Iran 16
PE - Perù 16
IL - Israele 15
RO - Romania 15
OM - Oman 14
DZ - Algeria 13
GR - Grecia 13
JM - Giamaica 13
KZ - Kazakistan 13
AL - Albania 11
CL - Cile 11
BJ - Benin 10
DO - Repubblica Dominicana 10
GT - Guatemala 10
LB - Libano 10
RS - Serbia 10
TT - Trinidad e Tobago 10
PT - Portogallo 9
TW - Taiwan 9
HN - Honduras 8
BO - Bolivia 7
GE - Georgia 7
NI - Nicaragua 7
PA - Panama 7
AZ - Azerbaigian 6
BH - Bahrain 6
BY - Bielorussia 6
EU - Europa 6
HU - Ungheria 6
PS - Palestinian Territory 6
BB - Barbados 5
ET - Etiopia 5
KG - Kirghizistan 5
KW - Kuwait 5
AM - Armenia 4
BN - Brunei Darussalam 4
CR - Costa Rica 4
DK - Danimarca 4
EE - Estonia 4
GY - Guiana 4
MN - Mongolia 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 45.667
Salva come PNG Salva come JPEG
Città #
Fairfield 2.489
Ashburn 2.453
Woodbridge 2.051
Hong Kong 1.883
Singapore 1.837
Houston 1.392
Dallas 1.389
San Jose 1.275
Chandler 1.180
Ann Arbor 1.165
Santa Clara 1.113
Seattle 1.077
Serra 989
Wilmington 864
Cambridge 863
Sofia 709
Shanghai 697
Milan 649
Beijing 609
New York 500
Boardman 366
Princeton 343
Council Bluffs 338
Ottawa 313
Los Angeles 311
Pisa 306
Lawrence 286
Helsinki 277
Medford 266
Lauterbourg 253
Ho Chi Minh City 236
Nanjing 195
Jacksonville 186
Des Moines 182
Izmir 181
Dong Ket 174
Hefei 153
Munich 151
Hanoi 148
São Paulo 140
Istanbul 132
Florence 127
Buffalo 124
Redondo Beach 124
San Diego 124
Tokyo 124
London 121
Rome 115
Columbus 114
The Dalles 113
Frankfurt am Main 108
Seoul 102
Dearborn 87
Abidjan 84
Boulder 65
Nanchang 63
Rio de Janeiro 56
Ogden 55
Kunming 52
Changsha 48
Chicago 48
Paris 47
Redwood City 47
Bremen 46
Da Nang 45
Shenyang 44
Turku 44
Warsaw 44
Phoenix 43
Falls Church 42
Dakar 41
Hebei 41
Fuzhou 40
Norwalk 40
Nuremberg 39
Baghdad 38
Belo Horizonte 37
Brussels 37
Tashkent 36
Bern 34
Orem 33
Johannesburg 32
Pune 32
Brooklyn 31
Jüchen 31
Vienna 31
Amsterdam 30
Montreal 30
San Francisco 30
Washington 30
Tianjin 29
Toronto 29
Dhaka 28
Jiaxing 28
Brasília 27
Haiphong 27
Jakarta 26
Lagos 26
Chennai 25
Curitiba 25
Totale 33.340
Salva come PNG Salva come JPEG
Nome #
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 374
Autoimmune thyroid disorders 302
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 254
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 247
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 243
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 237
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 230
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 228
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 227
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 227
Sorafenib in the treatment of thyroid cancer 226
Molecular testing in the diagnosis of differentiated thyroid carcinomas 225
Aggressive thyroid cancer: targeted therapy with sorafenib 223
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 217
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 216
Sunitinib in the treatment of thyroid cancer 214
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 212
Evaluation of the Anti-Spike (RDB) IgG Titer among Workers Employed at the University of Pisa Vaccinated with Different Types of SARS-CoV-2 Vaccines 211
Sorafenib and Thyroid Cancer 211
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 210
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
B-cells and mixed cryoglobulinemia. 208
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 206
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 204
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 204
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 201
Analysis of survival at cardiac arrest in events occurred in work environments in the territory served by an operations center of the 118 of Tuscany 201
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 200
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 199
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 198
Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell line secretome 197
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 195
Selective use of vandetanib in the treatment of thyroid cancer 194
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 193
Cancer stem cells: perspectives of new therapeutical approaches for breast cancer 193
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 193
Biomarkers in the prevention and follow-up of workers exposed to asbestos 192
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 191
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 191
Cabozantinib in Thyroid Cancer 189
Novel therapies for thyroid autoimmune diseases: An update 189
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 189
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 189
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 188
Body composition and cardiac dimensions in elite rhythmic gymnasts 188
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 188
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 188
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 187
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 187
New insight in endocrine-related adverse events associated to immune checkpoint blockade 187
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 186
Thyroid disorders induced by checkpoint inhibitors 185
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 184
L’esperienza della Medicina del Lavoro della Azienda Ospedaliero-Universitaria Pisana nella sorveglianza sanitaria degli ex-esposti ad amianto, alla luce delle linee di indirizzo della regione Toscana 184
DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review 183
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 183
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 182
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 182
Cytokines and HCV-Related Disorders. 179
Cytokines and HCV-related autoimmune disorders 177
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 177
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 177
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 176
Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer Therapy 176
RET TKI: Potential Role in Thyroid Cancers 175
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 174
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 174
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 173
Novel treatments for anaplastic thyroid carcinoma 172
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 172
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 171
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 170
New targeted molecular therapies for dedifferentiated thyroid cancer. 169
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 169
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. 166
Stem cells: their role in breast cancer development and resistance to treatment. 166
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 166
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 166
3,5-diiodo-l-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. 165
New targeted therapies for anaplastic thyroid cancer. 165
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 164
The Endocrinology of Liver Disease. 163
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 163
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 163
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 162
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 162
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy 162
The association of Sjögren syndrome and autoimmune thyroid disorders 161
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 161
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 161
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 161
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 161
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 160
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 160
Serum mesothelin and other biomarkers: What have we learned in the last decade? 159
Chemokines in thyroid autoimmunity 158
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 158
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 158
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 158
Totale 19.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021480 0 0 0 0 0 0 0 0 0 0 0 480
2021/20223.378 70 154 119 214 554 460 97 223 171 145 228 943
2022/20233.428 502 409 225 306 373 504 58 249 498 15 242 47
2023/20242.900 290 325 359 228 426 521 144 107 47 54 100 299
2024/20259.576 203 372 132 586 885 1.130 776 543 880 1.213 1.005 1.851
2025/202611.818 860 1.377 1.583 988 1.012 1.097 1.767 559 687 1.201 382 305
Totale 46.910